Pancreatic Cancer Research

ResearcherUniversität UlmActive in the last 2 years

Tim Eiseler

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7819-4659; OpenAlex author ID A5080401180. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
32
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 8

  1. Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2026.09.027↗
  2. Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. Co-author DOI 10.1136/jitc-2024-010579↗
  3. An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial. Co-author DOI 10.1186/s12943-025-02406-7↗
  4. A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing. Co-author DOI 10.1038/s41598-024-60107-5↗
  5. Comparative Panel Sequencing of DNA Variants in cf-, ev- and tumorDNA for Pancreatic Ductal Adenocarcinoma Patients. Last author DOI 10.3390/cancers14041074↗
  6. Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication. Last author DOI 10.3390/cancers13194844↗
  7. Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. Co-author DOI 10.1016/j.scr.2016.08.007↗
  8. Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases. Last author DOI 10.1091/mbc.e13-06-0334↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Theodor Werner Seufferlein · 8 shared papers, 2014–2026 · strength 1.28
  2. Alexander Kleger · 5 shared papers, 2016–2026 · strength 0.90
  3. Anton Lahusen · 3 shared papers, 2024–2025 · strength 0.66
  4. Yuan‐Na Lin · 2 shared papers, 2024–2025 · strength 0.47
  5. Anton Wellstein · 2 shared papers, 2024–2025 · strength 0.47
  6. Thomas Jens Ettrich · 2 shared papers, 2022–2025 · strength 0.33
  7. Mareike Waldenmaier · 2 shared papers, 2021–2022 · strength 0.33
  8. Christopher J. Halbrook · 1 shared paper, 2026 · strength 0.20
  9. Alexander Muir · 1 shared paper, 2026 · strength 0.20
  10. Jennifer Brooke Valerin · 1 shared paper, 2026 · strength 0.20
  11. Chantal Allgöwer · 1 shared paper, 2026 · strength 0.20
  12. Austin D. Silva · 1 shared paper, 2026 · strength 0.20
  13. Rima Singh · 1 shared paper, 2026 · strength 0.20
  14. Kevin Christian Montecillo Gulay · 1 shared paper, 2026 · strength 0.20
  15. Alica K. Michels · 1 shared paper, 2026 · strength 0.20
  16. Aimee L Edinger · 1 shared paper, 2026 · strength 0.20
  17. David Kuang-Fu Chang · 1 shared paper, 2026 · strength 0.20
  18. Hervé Tiriac · 1 shared paper, 2026 · strength 0.20
  19. Rui Fang · 1 shared paper, 2025 · strength 0.19
  20. Phyllis F. Cheung · 1 shared paper, 2025 · strength 0.19
  21. Andrea Tannapfel · 1 shared paper, 2025 · strength 0.19
  22. Meinolf Karthaus · 1 shared paper, 2025 · strength 0.19
  23. Manfred Paul Lutz · 1 shared paper, 2025 · strength 0.19
  24. Jens Thomas Siveke · 1 shared paper, 2025 · strength 0.19
  25. Albrecht Stenzinger · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.